(S (NP (EX There)) (VP (VBP have) (VP (VBN been) (NP (NP (QP (JJR more) (IN than) (CD 850,000)) (JJ confirmed) (NNS cases)) (CC and) (NP (QP (IN over) (CD 48,000)) (NNS deaths))) (PP (IN from) (NP (NP (DT the) (JJ human) (NN coronavirus) (NN disease) (CD 2019) (PRN (-LRB- -LRB-) (NP (NNP COVID-19)) (-RRB- -RRB-)) (NN pandemic)) (, ,) (VP (VBN caused) (PP (IN by) (NP (NP (NN novel) (JJ severe) (JJ acute) (NN respiratory) (NN syndrome) (NN coronavirus)) (PRN (-LRB- -LRB-) (NP (NNP SARS-CoV-2)) (-RRB- -RRB-))))))) (, ,) (PP (IN in) (NP (NP (DT the) (NNP United) (NNPS States)) (ADVP (RB alone)))))) (. .))
(S (ADVP (RB However)) (, ,) (NP (EX there)) (VP (VBP are) (ADVP (RB currently)) (NP (NP (DT no) (JJ proven) (JJ effective) (NNS medications)) (PP (IN against) (NP (NNP COVID-19))))) (. .))
(S (NP (NN Drug) (VBG repurposing)) (VP (VBZ offers) (NP (NP (DT a) (JJ promising) (NN way)) (PP (IN for) (NP (NP (DT the) (NN development)) (PP (IN of) (NP (NP (NN prevention) (CC and) (NN treatment) (NNS strategies)) (PP (IN for) (NP (NNP COVID-19))))))))) (. .))
(S (NP (DT This) (NN study)) (VP (VBZ reports) (NP (NP (DT an) (JJ integrative) (, ,) (JJ network-based) (JJ deep) (NN learning) (NN methodology)) (SBAR (S (VP (TO to) (VP (VB identify) (NP (NP (JJ repurposable) (NNS drugs)) (PP (IN for) (NP (NP (NNP COVID-19)) (PRN (-LRB- -LRB-) (VP (VBN termed) (S (NP (NNP CoV-KGE)))) (-RRB- -RRB-))))))))))) (. .))
(S (ADVP (RB Specifically)) (, ,) (NP (PRP we)) (VP (VBP built) (NP (NP (DT a) (JJ comprehensive) (NN knowledge) (NN graph)) (SBAR (WHNP (WDT that)) (S (VP (VBZ includes) (NP (NP (NP (QP (CD 15) (CD million)) (NNS edges)) (PP (IN across) (NP (NP (CD 39) (NNS types)) (PP (IN of) (NP (NP (NNS relationships)) (VP (VBG connecting) (NP (NP (NNS drugs)) (, ,) (NP (NNS diseases)) (, ,) (NP (NNS genes)) (, ,) (NP (NNS pathways)) (, ,) (CC and) (NP (NNS expressions))))))))) (, ,) (PP (IN from) (NP (NP (DT a) (JJ large) (JJ scientific) (NN corpus)) (PP (IN of) (NP (QP (CD 24) (CD million)) (NNP PubMed) (NNS publications))))))))))) (. .))
(S (S (VP (VBG Using) (NP (NNP Amazon) (NNP AWS) (VBG computing) (NNS resources)))) (, ,) (NP (PRP we)) (VP (VBD identified) (NP (NP (CD 41) (JJ repurposable) (NNS drugs)) (PRN (-LRB- -LRB-) (PP (VBG including) (NP (NN indomethacin) (, ,) (NN toremifene) (CC and) (NN niclosamide))) (-RRB- -RRB-)) (SBAR (WHNP (WHNP (WP$ whose) (JJ therapeutic) (NN association)) (PP (IN with) (NP (NNP COVID-19)))) (S (VP (VBD were) (VP (VBN validated) (PP (IN by) (NP (NP (NP (JJ transcriptomic) (CC and) (JJ proteomic) (NNS data)) (PP (IN in) (NP (NNP SARS-CoV-2) (JJ infected) (JJ human) (NNS cells)))) (CC and) (NP (NP (NNS data)) (PP (IN from) (NP (VBG ongoing) (JJ clinical) (NNS trials)))))))))))) (. .))
(S (SBAR (IN While) (S (NP (DT this) (NN study)) (, ,) (PP (IN by) (NP (DT no) (NN means))) (VP (VBZ recommends) (NP (JJ specific) (NNS drugs))))) (, ,) (NP (PRP it)) (VP (VBZ demonstrates) (NP (NP (DT a) (JJ powerful) (JJ deep) (NN learning) (NN methodology)) (SBAR (S (VP (TO to) (VP (VB prioritize) (NP (VBG existing) (NNS drugs)) (PP (IN for) (NP (JJ further) (NN investigation))))))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ holds) (NP (NP (DT the) (NN potential)) (PP (IN of) (S (VP (VBG accelerating) (NP (NP (JJ therapeutic) (NN development)) (PP (IN for) (NP (NNP COVID-19))))))))))))) (. .))
